1. Pcsk9-Inhibition In Routine Clinical Practice: Real World Data From Germany. (August 2019) Authors: Waldmann, E.; Altenhofer, J.; Henze, K.; Parhofer, K.G. Journal: Atherosclerosis Issue: Volume 287(2019) Page Start: e38 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. German lipid clinic experience with adherence to PCSK-9-inhibitor therapy. (December 2020) Authors: Waldmann, E.; Altenhofer, J.; Henze, K.; Parhofer, K.G. Journal: Atherosclerosis Issue: Volume 315(2020) Page Start: e54 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Lipoprotein(a) concentrations and apolipoprotein-E isoforms. Issue 1 (July 2015) Authors: Waldmann, E.; Stark, R.G.; Altenhofer, J.; Henze, K.; Parhofer, K.G. Journal: Atherosclerosis Issue: Volume 241:Issue 1(2015) Page Start: e101 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Over 30 years of elaborate experience in LDL apheresis: An effective and well-tolerated treatment option for specific patient subgroups. (December 2020) Authors: Ull, A.T.; Waldmann, E.; Riks, I.; Parhofer, K.G. Journal: Atherosclerosis Issue: Volume 315(2020) Page Start: e26 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Poor sleep quality is associated with impaired glucose tolerance in women after gestational diabetes. (June 2015) Authors: Ferrari, U.; Künzel, H.; Tröndle, K.; Rottenkolber, M.; Kohn, D.; Fugmann, M.; Banning, F.; Weise, M.; Sacco, V.; Hasbargen, U.; Hutter, S.; Parhofer, K.G.; Kloiber, S.; Ising, M.; Seissler, J.; Lechner, A. Journal: Journal of psychiatric research Issue: Volume 65(2015:Jun.) Page Start: 166 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Understanding lipoprotein(a) metabolism: Rebound analyses of lipoprotein(a) and PCSK9 concentrations following regular lipoprotein apheresis treatment (the Lipare-study). (September 2016) Authors: Waldmann, E.; Ooi, E.M.; Barrett, P.H.R.; Chan, D.C.; Marcovina, S.M.; Watts, G.F.; Parhofer, K.G. Journal: Atherosclerosis Issue: Volume 252(2016) Page Start: e212 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Effects of lipoprotein apheresis on PCSK9 levels. (May 2015) Authors: Julius, U.; Milton, M.; Stoellner, D.; Rader, D.; Gordon, B.; Polk, D.; Waldmann, E.; Parhofer, K.G.; Moriarty, P.M. Journal: Atherosclerosis Issue: Volume 18(2015) Page Start: 180 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗